Xanodyne Pharmaceuticals, Inc.
Investment Company
| Name | Xanodyne Pharmaceuticals, Inc. |
|---|---|
| Sector | Healthcare |
| Country | United States |
| Initial Inv Date | 2005 |
| Business Focus | Specialty pharmaceutical company focusing on innovative products in the therapeutic areas of women's health and pain management |
| Contact |
7300 Turfway Road, Suite 300
Florence KY 41042 |
Xanodyne Pharmaceuticals, Inc., a specialty pharmaceutical company focusing on innovative products in the therapeutic areas of women’s health and pain management, today announced that the Bankruptcy Court for the District of Delaware has approved its bid to acquire the pharmaceutical assets of aaiPharma (PINK SHEET: AAIIQ). The deal terms included $209.25 million cash and additional non-cash consideration.
Read More >>News
TriZetto agrees to be acquired by Apax Partners for $22 per share
The TriZetto Group, Inc. announced today that it has entered into a definitive agreement to be acquired and taken private by funds advised by Apax Partners.
Capio announces closing of purchase of Unilabs’ majority shareholders’ stake
Capio today announced that it has closed its purchase of the entire stake of registered and bearer shares and options of Unilabs from its majority shareholders.
Apax Partners Acquires Qualitest Pharmaceuticals and Vintage Pharmaceuticals
Funds advised by Apax Partners have agreed to acquire Qualitest and Vintage Pharmaceuticals, a leading distributor and manufacturer of generic pharmaceuticals based in Huntsville, Alabama, USA.